Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 232 posts found.

judge-gavel-1461966002dbr

Teva’s cancer drug Bendeka protected from generics until 2031, judge rules

April 30, 2020
Business Services Bendeka, Teva, Teva and Eagle

A US federal judge has ruled that generic versions of the cancer treatment Bendeka infringe on four separate patents, and …

News
teva_copy

Teva’s Ajovy becomes first drug of its kind available on NHS for prevention of chronic migraine

March 12, 2020
Sales and Marketing NICE, Teva, ajovy, migraine, pharma

NICE has announced the authorisation of Teva’s anti-CGRP drug Ajovy (fremanezumab) for the prevention of chronic migraine in adult patients …

News
francesa

Teva’s Austedo fails in two paediatric Tourette’s syndrome trials

February 21, 2020
Medical Communications, Research and Development Austedo, Teva, pharma, tourette's

Israeli firm Teva has shared disappointing results for its vesicular monoamine transporter 2 (VMAT2) Austedo (deutetrabenazine) after it failed to …

News
teva_copy

FDA approves Teva’s Ajovy autoinjector for treatment of migraine

January 29, 2020
Research and Development, Sales and Marketing FDA, Teva, ajovy, migraine, pharma

Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …

News
4420456374_64a3d7e6aa_88_2

Top Ten most popular articles on Pharmafile.com this week

January 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, European Commission, FDA, Pakistan, Sanofi, Teva

Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA …

News
teva_copy

Teva to settle bribery lawsuit with $54 million payout

January 7, 2020
Manufacturing and Production, Sales and Marketing Teva, bribery, pharma

Israeli drug firm Teva has agreed to settle an ongoing lawsuit levying allegations of the company’s bribery of doctors, it …

News

Four perspectives from life sciences companies on multichannel engagement

August 23, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Biogen, GSK, Lifesciences, Teva, healthcare, pharma

By 2020, 70% of HCPs are expected to be digital natives, whose experiences with mobile, social, and digital technologies in …

News
teva_copy

Teva launch generic version of EpiPen for children

August 21, 2019
Research and Development Mylan, Teva, allergies, children, epipen, pharma

A generic version of Mylan’s EpiPen, manufactured by Teva, is now available for children weighing between 15kg and 30kg in …

News
teva_copy

Teva recall heart drug after carcinogen found in API

June 14, 2019
Medical Communications API, Contamination, NMDA, Teva, carcinogen, pharma, recall

Teva Pharmaceuticals has expanded its recall of losartan potassium tablets after detecting a possible carcinogen in an active pharmaceutical ingredient …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 17, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Gilead, J&J, JJ, Janssen, Mundipharma, Novartis, Teva, generics

Some big names – including Gilead, Janssen, Teva and Bristol-Myers Squibb – were in trouble this week after two separate …

News
teva_copy

Teva terminates Ajovy at Phase 3 in episodic cluster headache

April 24, 2019
Research and Development Teva, ajovy, headache, pharma

Israeli pharmaceutical firm Teva has announced its intention to terminate further development of its calcitonin gene-related peptide (CGRP) inhibitor Ajovy …

News
teva_canada_1

Teva’s Ajovy injection secures EU approval for the prevention of migraine

April 2, 2019
Manufacturing and Production, Sales and Marketing EU, Europe, Teva, ajovy, migraine, pharma

Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (fremanezumab) has been awarded marketing authorisation by the European …

News

Teva settles ‘pay-to-delay’ case with FTC

February 21, 2019
Business Services, Sales and Marketing FTC, Teva, antitrust, drugs, generics, monopoly

Teva Pharmaceuticals has settled a dispute with the Federal Trade Commission (FTC) over three separate federal court antitrust lawsuits involving …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10

Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …

News

Celltrion and Teva’s Herceptin biosimilar secures FDA approval in breast cancer

December 18, 2018
Manufacturing and Production, Sales and Marketing Herceptin, Herzuma, Teva, celltrion, pharma

Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by …

News

Latest content

Novo Nordisk partners with UNICEF to prevent global childhood obesity

September 21, 2023

EC approves Menarini Group’s Orserdu for breast cancer treatment

September 21, 2023

Pharmanovia acquires CNS portfolio from Sanofi

September 20, 2023

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023

EC approves Pfizer’s Litfulo for adolescents and adults with alopecia

September 19, 2023